Class Action Lawsuit Filed Against Reckitt Benckiser Group for Investor Losses in 2024

Reckitt Benckiser Group PLC Faces Class Action Lawsuit

A significant development has emerged regarding Reckitt Benckiser Group PLC (RBGLY), as Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, has initiated a class action lawsuit concerning investor losses. This comes as a crucial opportunity for individuals who invested in Reckitt securities between January 13, 2021, and July 28, 2024. The law firm is reaching out to affected investors, encouraging them to take action.

Context of the Lawsuit

The lawsuit alleges that Reckitt and certain of its officers made materially misleading statements about the company’s operations and financial prospects, which ultimately led to poor information being provided to investors. Specifically, the complaint addresses the impact of Reckitt's cow's milk-based formula, Enfamil, on preterm infants, reporting that the product may have increased their risk of developing necrotizing enterocolitis (NEC). Allegations further suggest that the company failed to disclose information that could have influenced sales and led to potential legal ramifications, casting doubts on the validity of earlier public statements made by Reckitt.

Who Can Join the Class Action?

Investors who purchased Reckitt securities during the defined Class Period may seek to join the class action. The law firm has made it easy for potential class members to review the details of the complaint by visiting their website at bgandg.com/RBGLY. Affected investors have until August 4, 2025, to request to be appointed as lead plaintiffs in the case, although participating in any eventual recovery does not necessitate being a lead plaintiff.

Legal Representation Without Upfront Costs

The law firm has assured investors that representation in this class action is available on a contingency fee basis. This means that they will only be compensated for out-of-pocket expenses and attorneys' fees if they achieve a successful recovery for their clients. Provisions include compensation that is typically a percentage of the total recovery, minimizing the financial risk for investors.

Why Choose Bronstein, Gewirtz & Grossman?

Recognized for its proficiency in handling securities fraud cases and shareholder derivative actions, Bronstein, Gewirtz & Grossman has successfully recovered significant amounts for numerous investors across the country. Their commitment to representing investors is reflected in their dedication to achieving justice and recovery following financial losses.

For ongoing updates regarding the lawsuit, investors can follow Bronstein, Gewirtz & Grossman on LinkedIn, X, Facebook, and Instagram.

Conclusion

The Reckitt Benckiser Group PLC class action represents a critical opportunity for affected investors to seek recovery for their losses. By joining this lawsuit, they may hold the company accountable under federal securities laws, ensuring greater transparency and integrity in corporate communications moving forward. Interested investors should act promptly to ensure their voice is heard in this significant legal matter.

For additional inquiries or to discuss the potential for joining the class action, investors can reach out directly to Peretz Bronstein or his Client Relations Manager, Nathan Miller, at Bronstein, Gewirtz & Grossman by calling 332-239-2660.